Please login to the form below

Not currently logged in
Email:
Password:

LentiGlobin

This page shows the latest LentiGlobin news and features for those working in and with pharma, biotech and healthcare.

bluebird bio to restart marketing of Zynteglo in EU after previous suspension

bluebird bio to restart marketing of Zynteglo in EU after previous suspension

Earlier this year, bluebird voluntarily withdrew marketing of Zynteglo (betibeglogene autotemcel) in the EU after safety events relating to LentiGlobin for sickle cell disease (SCD) were reported. ... In  March bluebird reported that it is ‘very

Latest news

More from news
Approximately 9 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    LentiGlobin (betibeglogene darolentivec), an Orphan Drug and Breakthrough Therapy from Bluebird Bio, corrects the defect causing beta thalassemia, a blood disorder that causes life-threatening anaemia. ... The initial studies for LentiGlobin in

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    7. LentiGlobin TDT – a gene therapy first for Europe. Gene therapy company Bluebird Bio is on course to gain approval for its first product this year – and Europe is expected to ... The Cambridge, Massachusetts-based firm filed its gene therapy

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    The Cambridge, Mass-based company is set to file the first of its four candidates, LentiGlobin TDT, a gene therapy for patients with the rare blood disorder beta thalassemia, by the ... Pharmaceutical Market Europe spoke to Bluebird’s CEO Nick Leschly

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...